Hiroyuki Kamakura
Toho University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroyuki Kamakura.
Journal of Natural Medicines | 2016
Sumiko Hyuga; Masashi Hyuga; Naohiro Oshima; Takuro Maruyama; Hiroyuki Kamakura; Tadatoshi Yamashita; Morio Yoshimura; Yoshiaki Amakura; Takashi Hakamatsuka; Hiroshi Odaguchi; Yukihiro Goda; Toshihiko Hanawa
It is generally accepted that the primary pharmacological activities and adverse effects of Ephedra Herb are caused by ephedrine alkaloids. Interestingly, our research shows that Ephedra Herb also has ephedrine alkaloid-independent pharmacological actions, such as c-MET inhibitory activity. This study describes the preparation of an ephedrine alkaloids-free Ephedra Herb extract (EFE) by ion-exchange column chromatography, as well as in vitro and in vivo evaluation of its pharmacological actions and toxicity. We confirmed that EFE suppressed hepatocyte growth factor (HGF)-induced cancer cell motility by preventing both HGF-induced phosphorylation of c-Met and its tyrosine kinase activity. We also investigated the analgesic effect of EFE. Although the analgesic effect of Ephedra Herb has traditionally been attributed to pseudoephedrine, oral administration of EFE reduced formalin-induced pain in a dose-dependent manner in mice. Furthermore, we confirmed the anti-influenza virus activity of EFE by showing inhibition of MDCK cell infection in a concentration-dependent manner. All assessments of toxicity, even after repeated oral administration, suggest that EFE would be a safer alternative to Ephedra Herb. The findings described here suggest that EFE has c-Met inhibitory action, analgesic effect, and anti-influenza activity, and that it is safer than Ephedra Herb extract itself. Therefore, EFE could be a useful pharmacological agent.
Journal of Natural Medicines | 2013
Yukie Kumeta; Takuro Maruyama; Daigo Wakana; Hiroyuki Kamakura; Yukihiro Goda
Shatavari—a famous Ayurveda materia medica used mainly as a tonic for women—is distributed in health food products all over the world. The Ayurvedic Pharmacopoeia of India identifies the botanical origin of shatavari as the tuberous root of Asparagus racemosus. We recently investigated by DNA analysis the botanical origin of shatavari products on the Japanese market. The results suggested that their botanical origin was Asparagus; however, species identification was difficult. In this study, we analyzed steroidal saponins, including those specific to this plant, in these products and confirmed their origin as A. racemosus. Next, alkaloid analyses of an authentic A. racemosus plant and these products were performed, because several papers have reported the isolation of a pyrrolo[1,2-a]azepine alkaloid, asparagamine A, from this plant. Our results suggest that neither plant material nor products contained asparagamine A. It has been pointed out that Stemona plants are sometimes mistaken for shatavari, because their tuberous roots have a similar shape to that of A. racemosus, and pyrrolo[1,2-a]azepine alkaloids are thought to be Stemona-specific. These data strongly suggest that A. racemosus does not contain asparagamine A, and that previous isolation of asparagamine A from materials claimed as originating from A. racemosus was likely caused by misidentification of Stemona plants as A. racemosus.
Journal of Natural Medicines | 2014
Kazumasa Zaima; Daigo Wakana; Yosuke Demizu; Yukie Kumeta; Hiroyuki Kamakura; Takuro Maruyama; Masaaki Kurihara; Yukihiro Goda
A new amino acid–sesquiterpene adduct, isoheleproline (1), was isolated from the roots of Inula helenium (elecampane), together with four known sesquiterpene lactones (2–5). The planar configuration of 1 was elucidated on the basis of spectroscopic data analysis, and the relative configuration of 1 was determined by performing a detailed analysis of NOESY correlations and comparing its physicochemical data with the d- and l-proline adducts of 2 obtained by Michael addition. This is the first report of a new amino acid–sesquiterpene adduct from Inula plants.
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2008
Ruri Kikura-Hanajiri; Maiko Kawamura; Nahoko Uchiyama; Jun Ogata; Hiroyuki Kamakura; Kazuhiro Saisho; Yukihiro Goda
Journal of Health Science | 2006
Teruki Matsumoto; Ruri Kikura-Hanajiri; Hiroyuki Kamakura; Nobuo Kawahara; Yukihiro Goda
Chemical & Pharmaceutical Bulletin | 2011
Yosuke Demizu; Daigo Wakana; Hiroyuki Kamakura; Masaaki Kurihara; Haruhiro Okuda; Yukihiro Goda
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2008
Takuro Maruyama; Hiroyuki Kamakura; Ruri Kikura-Hanajiri; Yukihiro Goda
Journal of Natural Medicines | 2016
Naohiro Oshima; Tadatoshi Yamashita; Sumiko Hyuga; Masashi Hyuga; Hiroyuki Kamakura; Morio Yoshimura; Takuro Maruyama; Takashi Hakamatsuka; Yoshiaki Amakura; Toshihiko Hanawa; Yukihiro Goda
Chemical & Pharmaceutical Bulletin | 2007
Takuro Maruyama; Naoki Sugimoto; Masanori Kuroyanagi; Ik Hwi Kim; Hiroyuki Kamakura; Takeshi Kawasaki; Masao Fujita; Hiroshi Shimada; Yutaka Yamamoto; Atsuko Tada; Takeshi Yamazaki; Yukihiro Goda
Journal of Natural Medicines | 2015
Naohiro Oshima; Kazumasa Zaima; Hiroyuki Kamakura; Akane Hamato; Yutaka Yamamoto; Dong Hyo Kang; Tsuguo Yokokura; Yukihiro Goda; Takashi Hakamatsuka; Takuro Maruyama